openPR Logo
Press release

Pranlukast Market Expected to Hit USD 2.58 Billion by 2032 with a Remarkable 4.18% CAGR

07-15-2025 02:27 PM CET | Health & Medicine

Press release from: Market Research Future

Pranlukast Market Expected to Hit USD 2.58 Billion by 2032 with

Pranlukast Market: Rising Demand for Anti-Asthmatic Therapies Drives Growth in Allergy Treatment Segment. The Pranlukast Market is gaining attention within the global pharmaceutical industry, especially as respiratory disorders like asthma and allergic rhinitis continue to affect millions of people worldwide. Pranlukast, a leukotriene receptor antagonist, is commonly prescribed as an anti-inflammatory agent to manage chronic asthma and seasonal allergies, particularly in pediatric and adult populations who are unresponsive to corticosteroids alone.

Market Overview

Pranlukast belongs to a class of anti-asthmatic medications that works by blocking leukotrienes, inflammatory chemicals involved in the pathophysiology of asthma and allergic conditions. While widely used in several Asian countries including Japan and South Korea, the drug is increasingly being explored in new markets for its efficacy, safety profile, and role in combination therapies.

Growing awareness about asthma management, coupled with the increasing demand for personalized medicine and long-term respiratory care, is contributing to the gradual expansion of the Pranlukast market across developing and emerging economies.

As per MRFR analysis, the Pranlukast Market Size was estimated at 1.68 (USD Billion) in 2023.The Pranlukast Industry is expected to grow from 1.78(USD Billion) in 2024 to 2.58 (USD Billion) by 2032. The Pranlukast Market CAGR (growth rate) is expected to be around 4.18% during the forecast period (2024 - 2032).

Request Sample Copy of Report: (Including Full TOC, List of Tables & Figures, Chart :
https://www.marketresearchfuture.com/sample_request/27136

Market Growth

The Pranlukast market is projected to grow steadily over the coming years, supported by:

• Rising prevalence of asthma, particularly in urban populations and children

• Increased access to generic and branded formulations in Asia-Pacific and Latin America

• Growing emphasis on maintenance therapies for chronic respiratory diseases

Expansion of online pharmacies and telemedicine
boosting prescription rates in rural and semi-urban areas
Moreover, pharmaceutical companies are investing in clinical trials to explore Pranlukast's potential beyond asthma treatment, including applications in atopic dermatitis and inflammatory bowel disease, further expanding its market scope.

Key Companies in the Pranlukast Market Include:

• Intas Pharmaceuticals Ltd.
• Mylan N.V.
• Cadila Healthcare Limited
• Teva Pharmaceutical Industries Ltd.
• Ipca Laboratories Ltd.
• Sandoz International GmbH
• Emcure Pharmaceuticals Ltd.
• Torrent Pharma
• Glenmark Pharmaceuticals Ltd.
• Torrent Pharmaceuticals Ltd.
• AstraZeneca
• Cipla Ltd.
• Dr. Reddy's Laboratories Ltd.
• Aurobindo Pharma Limited
• Lupin

Market Dynamics

Key Drivers
• High global burden of respiratory disorders: Asthma affects over 250 million people globally, creating consistent demand for bronchodilator and leukotriene-modifying agents.

• Preference for oral therapies: Pranlukast's oral administration makes it preferable for long-term use, especially in pediatric care.

• Generic availability: Generic drug manufacturers are entering the market, making treatment more affordable and accessible.

Challenges
• Limited approval in Western markets: Pranlukast is not yet approved in the US and many parts of Europe, which restricts global adoption.

• Competition from alternative therapies: Drugs like montelukast dominate many regions, posing a challenge to market penetration.

• Side-effect concerns: Though generally well-tolerated, some leukotriene antagonists have been linked to neuropsychiatric side effects, affecting physician prescribing habits.

Direct Purchase this Research Report: https://www.marketresearchfuture.com/checkout?currency=one_user-USD&report_id=27136

Pranlukast Market Segmentation

• Pranlukast Treatment Type Outlook
• Asthma

Chronic Obstructive Pulmonary Disease (COPD)
• Pranlukast Drug Formulation Outlook
• Tablets
• Suspension
• Inhalers

Pranlukast Distribution Channel Outlook
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Pranlukast Dose Strength Outlook
• 75 mg
• 150 mg
• 300 mg

Pranlukast Regional Outlook
• North America
• Europe
• South America
• Asia Pacific
• Middle East and Africa

Future Outlook

The global Pranlukast market is expected to witness moderate but consistent growth through 2032. Market expansion is likely to be strongest in Asia-Pacific, where the drug is already established, with new growth opportunities in Latin America, Africa, and Eastern Europe due to increasing healthcare investments and awareness.

Comprehensive Overview: https://www.marketresearchfuture.com/reports/pranlukast-market-27136

Future growth will also depend on:

• Regulatory approvals in new geographies

• Innovative fixed-dose combinations with inhaled corticosteroids

• Research into additional indications, broadening its clinical utility

• Digital health tools enhancing prescription and patient compliance

Reasons to Buy the Pranlukast Market Report

✔️ In-depth analysis of market size, forecast, and competitive landscape
✔️ Insights into regional growth patterns and market accessibility
✔️ Assessment of key players, generic drug opportunities, and pipeline developments
✔️ Evaluation of emerging therapeutic applications for pranlukast beyond asthma
✔️ Strategic guidance for pharmaceutical firms, distributors, and investors entering respiratory care markets

The Pranlukast Market presents promising opportunities in respiratory and allergy therapeutics, especially in underserved regions. With a growing focus on long-term asthma control and generic drug expansion, stakeholders who invest early in this segment stand to benefit from consistent demand and innovation in the years ahead.

FAQs
What is driving the growth of the Pranlukast market?
Which regions dominate the Pranlukast market?
What are the main challenges facing the Pranlukast market?
What are the potential growth opportunities for Pranlukast in the future?
Who are the major players in the Pranlukast market?

Related Reports

AI in Medical Writing Market: https://www.marketresearchfuture.com/reports/ai-medical-writing-market-31280

Artificial Intelligence In Animal Health Market: https://www.marketresearchfuture.com/reports/artificial-intelligence-animal-health-market-31244

Acute Wound Care Market: https://www.marketresearchfuture.com/reports/acute-wound-care-market-8844

Pharma Social Media Market: https://www.marketresearchfuture.com/reports/pharma-social-media-market-32048

Bone Void Fillers Market: https://www.marketresearchfuture.com/reports/bone-void-filler-market-32038

Healthcare Interoperability Solution Market: https://www.marketresearchfuture.com/reports/healthcare-interoperability-solution-market-31976

Chiropractic Care Market: https://www.marketresearchfuture.com/reports/chiropractic-care-market-32293

Clinical Trial Supplies Market: https://www.marketresearchfuture.com/reports/clinical-trial-supplies-market-9183

Colorectal Cancer Screening Market: https://www.marketresearchfuture.com/reports/colorectal-cancer-screening-market-9203

Dental Cements Market: https://www.marketresearchfuture.com/reports/dental-cement-market-9274

Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. MRFR's approach combines the proprietary information with various data sources to give an extensive understanding to the client about the latest key developments, expected events and also about what action to take based on these aspects.

Market Research Future (Part of Wantstats Research and Media Private Limited)
99 Hudson Street, 5Th Floor
New York, NY 10013
United States of America
+1 628 258 0071 (US)
+44 2035 002 764 (UK)
Email: sales@marketresearchfuture.com
Website: https://www.marketresearchfuture.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Pranlukast Market Expected to Hit USD 2.58 Billion by 2032 with a Remarkable 4.18% CAGR here

News-ID: 4104910 • Views:

More Releases from Market Research Future

Crypto Wallet Market Size to Skyrocket to USD 135.98 Billion by 2035 Driven by Rapid Cryptocurrency Adoption
Crypto Wallet Market Size to Skyrocket to USD 135.98 Billion by 2035 Driven by R …
The Crypto Wallet Market report provides detailed insights into the market trends, competitive landscape, growth factors, and opportunities across global regions. Crypto Wallet Market Overview: The Crypto Wallet Market is witnessing exponential growth as the adoption of cryptocurrencies, digital assets, and blockchain-based applications accelerates worldwide. Crypto wallets enable secure storage, transfer, and management of digital currencies, private keys, and decentralized assets. Rising investor participation, growth of decentralized finance (DeFi), and increasing use
Payday Loans Market Forecast: Industry to Expand from USD 39.89 Billion in 2025 to USD 60.3 Billion by 2035
Payday Loans Market Forecast: Industry to Expand from USD 39.89 Billion in 2025 …
The Payday Loans Market serves as a critical source of short-term financing for consumers facing temporary cash flow shortages. Payday loans offer quick access to funds with minimal documentation, making them widely used among individuals with limited access to traditional banking services. Despite regulatory scrutiny, demand continues due to rising living costs, emergency expenses, and the growing need for fast, unsecured credit solutions. The Payday Loans Market Size was estimated
Venture Capital Market Forecast: Industry to Surge from USD 361.03 Billion in 2025 to USD 2,257.92 Billion by 2035
Venture Capital Market Forecast: Industry to Surge from USD 361.03 Billion in 20 …
The Venture Capital Market report provides detailed insights into the market trends, competitive landscape, growth factors, and opportunities across global regions. Venture Capital Market Overview: The Venture Capital Market plays a pivotal role in funding early-stage, high-growth startups and innovative businesses across technology, healthcare, fintech, and emerging sectors. Venture capital investments enable rapid product development, market expansion, and commercialization of disruptive ideas. Increasing digitalization, startup ecosystem expansion, and strong investor appetite for
Trade Finance Market Growth Outlook 2025-2035 with a CAGR of 7.42%
Trade Finance Market Growth Outlook 2025-2035 with a CAGR of 7.42%
The Trade Finance Market report provides detailed insights into the market trends, competitive landscape, growth factors, and opportunities across global regions. Trade Finance Market Overview: The Trade Finance Market plays a crucial role in facilitating international and domestic trade by reducing payment risks, improving cash flow, and ensuring smooth movement of goods across borders. Trade finance instruments such as letters of credit, guarantees, supply chain finance, and export credit enable businesses to

All 5 Releases


More Releases for Pranlukast

Healthcare Consulting Services Market Growth Outlook: USD 73.6 Billion by 2035 W …
The Healthcare Consulting Services Market has emerged as a critical pillar supporting the transformation of global healthcare systems, reflecting the industry's increasing complexity, regulatory demands and technological evolution. As healthcare organizations navigate challenges including rising costs, workforce shortages, digital transformation imperatives and value-based care models, the demand for specialized consulting expertise continues to surge. From strategic planning and operational optimization to IT implementation, regulatory compliance and financial management, consulting services
Hearing Aids Market Growth: Valued at USD 13.16 Billion in 2024, Expected to Hit …
Hearing Aids Market: Market Overview, Key Market Segments, Industry Latest News, Key Companies, Market Drivers, and Regional Insights The global hearing aids market has witnessed steady growth over the past decade, driven by an increasing prevalence of hearing disorders, technological advancements in auditory devices, and a growing geriatric population. Hearing aids are electronic sound amplification devices designed to help individuals with hearing impairments by improving their hearing capabilities. The market has
Medical Billing Market Growth Forecast Report 2032 | Advancements in AI, Cloud T …
Market Overview The medical billing market is expected to witness significant growth through 2032, driven by the increasing demand for efficient billing solutions across healthcare sectors. It is segmented by type into professional and institutional billing, catering to different service providers. Applications span database management, financial operations, infrastructure, and operational functions, ensuring seamless billing processes. Additionally, the market is influenced by the adoption of electronic billing, payment systems, and outsourced medical billing services, which
Stretch Ceilings Market Size and Forecast
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- The global Stretch Ceilings Market is expected to record a CAGR of XX.X% from 2024 to 2031 In 2024, the market size is projected to reach a valuation of USD XX.X Billion. By 2031 the valuation is anticipated to reach USD XX.X Billion. The stretch ceilings market encompasses a wide array of products and services catering to the demand for flexible and aesthetically pleasing ceiling solutions. It includes
Anti-Asthma Drugs Market Anticipated To Touch USD 28.3 Billion Till 2023 with Wo …
Anti-Asthma Drugs Market - Segmentation The Global Anti-Asthma Drugs Market has been segmented on the basis of drug class, route of administration, therapy, trigger, type, and lastly, region. On the basis of drug class, this market has been segmented into bronchodilators, corticosteroids, leukotriene antagonists, mast cell stabilizers, monoclonal antibody, and others. Bronchodilators have been further segmented into anticholinergics, beta agonists, and Xanthines. Based on the route of administration, the market has been
Anti Asthma Drugs Market 2018; Leading Players Baxter International, Baxter Inte …
The Global Anti-Asthma Drugs Market has been segmented on the basis of drug class, route of administration, therapy, trigger, type, and lastly, region. On the basis of drug class, this market has been segmented into bronchodilators, corticosteroids, leukotriene antagonists, mast cell stabilizers, monoclonal antibody, and others. Bronchodilators have been further segmented into anticholinergics, beta agonists, and Xanthines. Based on the route of administration, the market has been segmented into inhaled, intravenous,